COMPANY PROFILE · UPDATED 18 NOV 2025

EGenesis

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.

egenesisbio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2015
Headcount: 120
Open roles: 14
Last raised: Series D · Sign in to view

TECH STACK

How EGenesis builds

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at EGenesis

View all 14 open roles →

FUNDING

Capital raised

Total raised

$456,000,000

Investors

Khosla VenturesAlexandria Real Estate EquitiesAlta PartnersAltium CapitalArch Venture PartnersBerggruen HoldingsBiomatics Capital PartnersCatalio Capital ManagementDaVitaE Squared Capital ManagementEisai InnovationFan VenturesFarallon Capital ManagementFresenius Medical Care North AmericaHBM Healthcare InvestmentsHeritage Provider NetworkInvus GroupIrving InvestorsJDRF T1D FundLeaps by BayerLifeSci Venture PartnersLux CapitalMonashee Investment ManagementNatco PharmaOUP (Osage University Partners)ParkwoodPolaris PartnersSamsara BioCapitalSymBiosisUprisingWellington Partners

Funding rounds

Series D
Lux Capital, Farallon Capital Management, Alta Partners, Arch Venture Partners, Khosla Ventures, Leaps by Bayer, Natco Pharma, DaVita, Fresenius Medical Care North America, Parkwood, Eisai Innovation
$191MSep 3, 2024
Series C
Irving Investors, LifeSci Venture Partners, Monashee Investment Management, OUP (Osage University Partners), Farallon Capital Management, Altium Capital, Samsara BioCapital, SymBiosis, Polaris Partners, HBM Healthcare Investments, Fresenius Medical Care North America, Leaps by Bayer, Khosla Ventures, Wellington Partners, Catalio Capital Management, Arch Venture Partners, Invus Group, Alta Partners
$125MMar 1, 2021
Series B
Fresenius Medical Care North America, Khosla Ventures, Biomatics Capital Partners, Wellington Partners, Leaps by Bayer, Alta Partners, Arch Venture Partners
$100MNov 6, 2019
Series A
Arch Venture Partners, Biomatics Capital Partners, Khosla Ventures, Alta Partners, Alexandria Real Estate Equities, Heritage Provider Network, Berggruen Holdings, Uprising, Fan Ventures, JDRF T1D Fund, E Squared Capital Management
$38MMar 15, 2017
Convertible Note
$2MAug 22, 2016

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Khosla Ventures

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

React

LOCATIONS

Where they work

EGenesis offices

Loading map…

Cambridge, MA300 Technology Square
Madison, WI